Gene therapy treatment being considered for approval in Europe - Blogs Allvoices

Blogs Posts Related To: Gene therapy treatment being considered for approval in Europe

By arkar send a private message
Brussels : Belgium | 10 months ago  
While it may sound invasive, gene therapies, used to alter a person’s DNA usually in the case of hereditary diseases, will be shortly approved for sale and prescription in Europe...
    • Clear
    • Share:
    • Share
    • Clear
    • Clear
    • Clear
    • Clear
     
  • Read full report
Reach Credibility Credibility of 5
Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

Related Blogs

  • First gene therapy in West, for a rare disease, on the horizon ...

    www.stemcellmedicine.tv | 2 months ago
    ... of a gene therapy treatment for disease in the West. The European Medicine Agency's Committee for Medicinal Products for Human Use said Friday that it is recommending approval of Glybera, a treatment for lipoprotein lipase deficiency ...
  • UniQure's gene therapy first up for approval in West - FiercePharma

    www.fiercepharma.com | 2 months ago
    It took four attempts, but UniQure's Glybera has been recommended for approval by the European Medicines Agency as the first gene therapy treatment in a Western nation. It is for treatment of the rare condition lipoprotein lipase deficiency, ...
  • UniQure's gene therapy for lipoprotein lipase deficiency recommended

    europe-health-care.eu | 2 months ago
    UniQure's gene therapy for lipoprotein lipase deficiency recommended for approval as Orphan Drug. uniQure announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a ...
  • First Gene Therapy in Western World Receives Positive Opinion in ...

    www.stemcellmedicine.tv | 2 months ago
    uniQure has developed Glybera as a therapy for patients with the genetic disorder lipoprotein lipase deficiency. LPLD is an orphan disease for which no treatment exists today. The disease is caused by mutations in the LPL gene, resulting in ...
  • Non-DMD gene therapy nearing regulatory approval in Europe ...

    community.parentprojectmd.org | 2 months ago
    This would be the first regulatory approval for a gene therapy in the Western world. It treats lipoprotein lipase deficiency, a rare genetic disorder. Interesting article... http://www.nytimes.com/2012/07/21/health/european-agency-recommends.


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.